2022
DOI: 10.53964/jmn.2022003
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Safety of Albumin-bound Paclitaxel Versus Solvent-based Paclitaxel in Breast Cancer: A Meta-analysis

Abstract: Objective: A meta-analysis was performed to evaluate the safety and efficacy of albumin-bound paclitaxel (Nab-PTX) versus solvent-based paclitaxel (Sb-PTX) for breast cancer. Methods: In this systematic review and network meta-analysis, we searched databases including PubMed, Embase, and Cochrane-Library, for randomized controlled trials on the safety and efficacy of Nab-PTX and Sb-PTX for breast cancer. Pathologic complete response (pCR), objective response rate (ORR), and adverse events (AEs) were collated… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Therefore, most of the current treatment schemes for NSCLC are platinumbased combined chemotherapy [15]. Paclitaxel is commonly used in the treatment of NSCLC and is effective when combined with cisplatin [16].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, most of the current treatment schemes for NSCLC are platinumbased combined chemotherapy [15]. Paclitaxel is commonly used in the treatment of NSCLC and is effective when combined with cisplatin [16].…”
Section: Discussionmentioning
confidence: 99%